Total Funding
87
62
Total FundingSeries A raised
Growth Score
-3 pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
113201
VAXDIGM is a biotechnology company that focuses on the development of advanced vaccines and future vaccines.
- Moon Sang-ki: Chief Operating Officer and Vice President
- Lee Ha-na: Chief Finance Officer and Vice President
About the Company
VAXDIGM is a biotechnology company designed to advance the development of improved vaccines. VAXDIGM rapid development of various synthetic antigen vaccines with improved cost-effectiveness, safety, and stability.
